Crossmark

Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale

Published Online: 2016-10-04

Published Print: 2016-10

Authors

Rachlis, Beth

Karwa, Rakhi

Chema, Celia

Pastakia, Sonak

Olsson, Sten

Wools-Kaloustian, Kara

Jakait, Beatrice

Maina, Mercy

Yotebieng, Marcel

Kumarasamy, Nagalingeswaran

Freeman, Aimee

de Rekeneire, Nathalie

Duda, Stephany N.

Davies, Mary-Ann

Braitstein, Paula
Funding

Funding for this research was provided by:

National Institutes of Health (U01AI069923)

National Institutes of Health (U01AI069907)

National Institutes of Health (U01A096299)

National Institutes of Health (U01AI069911)

National Institutes of Health (U01AI069919)

National Institutes of Health (U01AI069918)

National Institutes of Health (U01AI069924)

U.S. President’s Emergency Plan for AIDS Relief (AID-623-A-12-0001)
License Information

Text and Data Mining valid from 2016-10-01

Version of Record valid from 2016-10-04
More Information

Article History

First Online: 4 October 2016

Document is current